⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy

Official Title: Multicenter Prospective Randomized Controlled Trial of Comparing Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy for Upper Third Early Gastric Cancer (KLASS-05)

Study ID: NCT02892643

Conditions

Gastric Cancer

Study Description

Brief Summary: Experimental: Laparoscopic proximal gastrectomy Laparoscopy proximal gastrectomy with esophago-jejunostomy, gastro-jejunostomy and jejuno-jejunostomy (double tract reconstruction). Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy. Active Comparator: Laparoscopic total gastrectomy Laparoscopic total gastrectomy with esophago-jejunostomy and jejuno-jejunostomy (Roux-en-Y reconstruction). Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy.

Detailed Description: Participating Surgeons Prior to this clinical trial, only the surgeons who are considered to have the standardization by review committee participated. Patients Registration It is required to ensure that the patients meet the inclusion criteria for this clinical trial, are free from any items of exclusion criteria, are explained about the participation in the clinical trial along with the informed consent forms. After rechecking the patients with the registration check list by accessing the web-based randomized program provided from Seoul National University Bundang Hospital Medical Research Collaborating Center. Each group 69 patients, total 138 subjects will be enrolled. Randomization The registration randomization should be done with 1:1 ratio for each researcher. Baseline number (BN) should be provided to the subjects in the order of acquisition of informed consent form. Based on the subjects who are selected as the appropriate subjects in the end, the allocation number (AN) shall be provided in the order of randomized allocation table. Procedure Operations are performed according to the allocated group.

Keywords

Eligibility

Minimum Age: 20 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Soonchunhyang University Bucheon Hospital, Bucheon, , Korea, Republic of

Dong-A University Hospital, Busan, , Korea, Republic of

Dankook University Hospital, Cheonan, , Korea, Republic of

Keimyung University Hospital, Daegu, , Korea, Republic of

Chungnam National University Hospital, Daejeon, , Korea, Republic of

Eulji University Hospital, Deajon, Daejeon, , Korea, Republic of

Chonnam National University Hospital, Hwasun, , Korea, Republic of

National Cancer Center, Ilsan, , Korea, Republic of

Pusan National University Hospital, Pusan, , Korea, Republic of

Seoul National University Bundang Hospital, Seongnam, , Korea, Republic of

Ewha Womans University Medical Center, Seoul, , Korea, Republic of

Seoul National University Hospital, Seoul, , Korea, Republic of

Seoul St. Mary's Hospital, Seoul, , Korea, Republic of

Yeouido St. Mary's Hospital, Seoul, , Korea, Republic of

Yonsei University Severance Hospital, Seoul, , Korea, Republic of

Ajou University Hospital, Suwon, , Korea, Republic of

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: